Profile data is unavailable for this security.
About the company
Zhejiang Medicine Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of drugs and nourishments. The Company mainly provides nourishments for animals and human, health care products, and chemicals and chemical raw materials, among others. The Company's products include synthetic vitamin E, natural vitamin E soft capsules, Beta carotene, vancomycin hydrochloride for injection and teicoplanin for injection, among others. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)8.04bn
- Net income in CNY425.74m
- Incorporated1997
- Employees6.23k
- LocationZhejiang Medicine Co LtdNo. 168 Zhiyuanzhong AvenueBinhai XinchengSHAOXING 312366ChinaCHN
- Phone+86 57 585211969
- Fax+86 57 585211976
- Websitehttps://www.zmc.top/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Animal Husbandry Industry Co., Ltd | 5.47bn | 339.08m | 9.01bn | 4.33k | 26.56 | 1.61 | -- | 1.65 | 0.3321 | 0.3321 | 5.36 | 5.48 | 0.6331 | 4.13 | 4.89 | 1,264,384.00 | 3.33 | 6.23 | 4.71 | 9.01 | 18.95 | 24.29 | 5.26 | 8.69 | 1.86 | -- | 0.2017 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
Shenzhen Chipscreen Biosciences Co Ltd | 547.79m | 103.01m | 9.01bn | 1.06k | 84.99 | 5.29 | -- | 16.45 | 0.2578 | 0.2578 | 1.33 | 4.15 | 0.1761 | 1.66 | 3.97 | 518,248.70 | 2.14 | 1.32 | 2.61 | 1.54 | 86.99 | 93.29 | 12.17 | 6.97 | 2.99 | -- | 0.4037 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
Guobang Pharma Ltd | 5.28bn | 616.22m | 9.31bn | 4.23k | 15.11 | 1.22 | -- | 1.76 | 1.10 | 1.10 | 9.44 | 13.61 | 0.5231 | 2.78 | 8.16 | 1,247,457.00 | 6.08 | 10.36 | 7.86 | 14.24 | 22.91 | 27.49 | 11.63 | 15.01 | 1.82 | -- | 0.2047 | 18.24 | -6.49 | 10.28 | -33.49 | 23.77 | 35.60 | -- |
Zhejiang Medicine Co., Ltd. | 8.04bn | 425.74m | 9.62bn | 6.23k | 22.31 | 0.9845 | -- | 1.20 | 0.447 | 0.447 | 8.41 | 10.13 | 0.6329 | 2.91 | 5.57 | 1,290,409.00 | 2.14 | 4.32 | 2.75 | 5.68 | 31.16 | 36.57 | 3.39 | 6.28 | 1.62 | 5.95 | 0.0819 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
Zhejiang Hisun Pharmaceutical Co., Ltd. | 11.99bn | 615.06m | 9.86bn | 8.33k | 15.70 | 1.10 | -- | 0.8218 | 0.5198 | 0.5198 | 10.05 | 7.45 | 0.6539 | 4.01 | 4.93 | 1,440,682.00 | 3.41 | 1.75 | 5.60 | 3.46 | 41.27 | 40.92 | 5.22 | 3.19 | 0.7195 | 6.05 | 0.4156 | 36.54 | -0.8221 | 2.63 | 0.443 | 104.82 | -18.35 | 27.73 |
Aurisco Pharmaceutical Co Ltd | 1.30bn | 325.73m | 9.92bn | 1.52k | 30.40 | 4.77 | -- | 7.65 | 0.803 | 0.803 | 3.18 | 5.12 | 0.5404 | 1.17 | 4.99 | 852,082.90 | 13.57 | 12.40 | 16.46 | 14.33 | 56.90 | 51.26 | 25.12 | 23.05 | 1.72 | -- | 0.116 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
Jinyu Bio-Technology Co Ltd | 1.58bn | 282.51m | 10.24bn | 1.65k | 35.31 | 1.81 | -- | 6.47 | 0.2588 | 0.2588 | 1.44 | 5.05 | 0.2365 | 2.06 | 1.98 | 956,543.20 | 4.09 | 4.82 | 4.79 | 5.68 | 57.97 | 58.78 | 17.28 | 19.91 | 3.33 | -- | 0.0043 | 36.41 | 4.55 | -3.37 | 34.63 | -17.77 | -12.92 | -25.56 |
Data as of Mar 13 2024. Currency figures normalised to Zhejiang Medicine Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 19.76m | 2.06% |
Shanghai Wealspring Asset Management Co. Ltd.as of 30 Jun 2023 | 4.77m | 0.50% |
Galaxy Asset Management Co., Ltd.as of 30 Jun 2023 | 3.16m | 0.33% |
GF Fund Management Co., Ltd.as of 30 Jun 2023 | 2.66m | 0.28% |
The Vanguard Group, Inc.as of 05 Apr 2024 | 2.33m | 0.24% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 1.65m | 0.17% |
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2023 | 1.58m | 0.16% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 1.12m | 0.12% |
China Asset Management Co., Ltd.as of 30 Jun 2023 | 1.11m | 0.12% |
Vanguard Global Advisers LLCas of 31 Mar 2024 | 837.20k | 0.09% |
More ▼
Data from 30 Jun 2023 - 22 Apr 2024Source: FactSet Research Systems Inc.